American Oncology Network, Inc.
AONC
$4.80
$0.000.00%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -129.52% | 146.18% | -109.09% | -138.27% | 196.97% |
Total Depreciation and Amortization | -0.96% | 2.82% | 8.83% | 5.88% | -5.76% |
Total Amortization of Deferred Charges | -16.74% | 0.00% | -0.92% | 0.00% | 22.60% |
Total Other Non-Cash Items | 158.12% | -33.06% | 69.50% | 40.50% | -674.20% |
Change in Net Operating Assets | -2.10% | -165.75% | 950.88% | -57.14% | 961.43% |
Cash from Operations | 17.24% | -175.16% | 477.46% | -207.48% | -100.26% |
Capital Expenditure | -59.55% | 2.13% | -49.93% | -4.87% | 36.24% |
Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -100.00% |
Cash Acquisitions | 100.00% | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 140.98% | 57.45% | 164.22% | 44.05% | -3,589.14% |
Cash from Investing | 975.66% | -212.55% | 114.01% | 40.86% | -400.93% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 33.21% | -1,146.50% | 23.79% | -33.77% | -20.31% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | 100.00% | -3,538.14% | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -625.33% | 84.01% |
Other Financing Activities | -- | -- | -- | -100.04% | 219.40% |
Cash from Financing | 76.18% | -2,059.84% | 13.90% | -124.62% | -97.80% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 65.02% | -188.62% | 300.77% | -9.78% | -143.09% |